Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Thermal power to dominate Algeria’s generation mix through 2035 despite renewable push, forecasts GlobalData

Algeria is accelerating its energy transition, supported by government policy, strong renewable energy sources potential, and sustainability targets. Despite ambitious renewable targets, thermal power capacity (especially gas-fired power) remains central because of the existing infrastructure and natural gas reserves, and is estimated to account for a dominant share of 85.2% of the country’s power generation […]
Read more

US venture capital market begins with fewer deals but 4x YoY jump in value in January 2026, reveals GlobalData

The US venture capital (VC) market began 2026 with a pronounced divergence between deal activity and capital deployment, as deal volume contracted while funding value surged sharply. The total number of VC deals announced in January 2026 declined by around 15% year-on-year (YoY), yet total funding value jumped more than fourfold (4x) to $65 billion, […]
Read more

AbbVie’s $100 billion US deal and FDA reforms highlight growing focus on domestic manufacturing, says GlobalData

AbbVie’s $100 billion agreement with the US administration signals a structural recalibration of drug pricing negotiations, tying tariff exemptions and pricing flexibility directly to domestic manufacturing expansion. Coupled with the evolving US Food and Drug Administration manufacturing reforms, the deal underscores a policy-driven shift that embeds capital investment, supply chain resilience, and advanced biologics capacity […]
Read more

Non-traditional partnerships to play key role in insurance transformation, reveals GlobalData

Partnerships between insurers and non-traditional technology and service providers are expected to play an increasingly important role in shaping future insurance offerings, according to a survey conducted by GlobalData, a leading intelligence and productivity platform. A GlobalData poll, conducted on Life Insurance International and concluded in Q1 2026, found that 41.1% of respondents identified partnerships […]
Read more

Steep M&A fall pulls down overall APAC deal activity by 36% YoY in January 2026, reveals GlobalData

A steep 49% year-on-year (YoY) fall in mergers & acquisitions (M&A) activity weighed heavily on the Asia-Pacific (APAC) deal activity in January 2026, pulling the overall transaction volumes (M&A, private equity and venture financing) down 36%. This reflects a more cautious environment among the corporates and investors amid the persistent macro uncertainty and tighter funding […]
Read more

Cisco Live EMEA 2026: Cisco sets itself apart with broad AI approach to collaboration, says GlobalData

As part of Cisco Live EMEA 2026, Cisco’s collaboration team announced upcoming, beta, and generally available AI features spanning devices, integrations and interoperability, and other areas. Cisco continues to support AI on a broad scale and has a set of capabilities spanning areas such as networking, security, and manageability to support that agenda, according to […]
Read more

Refillable and minimalist packaging reshapes makeup industry as sustainability-conscious consumers seek value, says GlobalData

Rising environmental awareness, mounting cost pressures, and increased scrutiny of beauty industry waste are reshaping consumer behavior within the makeup sector. Consumers are increasingly gravitating towards refillable systems and minimalist packaging formats that reduce plastic usage while offering long-term value. This shift is supported by a 2025 Q4 global consumer survey†, which found that 74% […]
Read more

Soccer accounts for 58% of EMEA non-alcoholic beverage sports sponsorship in 2025, reveals GlobalData

EMEA non-alcoholic beverage sponsorship is heavily concentrated in soccer, reflecting its unmatched, year-round audience scale and strong conversion potential that make it the sector’s primary driver of value. Soccer accounted for more than three times the value of the next-largest sport, motor racing in 2025, reveals GlobalData, a leading intelligence and productivity platform. GlobalData’s latest […]
Read more

Huayunuo approval positions China at forefront of viral hepatitis innovation, says GlobalData

Huahui Health has recently secured conditional approval from China’s National Medical Products Administration (NMPA) for Huayunuo (Libevitug Injection), marking it as the first domestically developed monoclonal antibody (mAb) drug for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis. This move not only addresses a critical treatment gap but also signals China’s […]
Read more

FDA reversal on Moderna’s mRNA-1010 can transform the seasonal influenza vaccines market, says GlobalData

The US Food and Drug Administration’s (FDA) decision to review Moderna’s mRNA-1010, with a Prescription Drug User Fee Act (PDUFA) date set for 05 August 2026, signals a pivotal inflection point for the seasonal influenza vaccines market. If approved, the candidate will introduce the first mRNA-based flu vaccine, potentially redefining production timelines, strain matching precision, […]
Read more

Agentic AI holds key to LLM profitability as enterprise token surge reshapes AI economics, says GlobalData

Agentic AI, not consumer chatbots, will determine whether trillion-dollar investments in large language models (LLMs) ever translate into sustainable profits. As enterprise deployments trigger a surge in application programming interface (API) calls and token consumption, energy intensity and infrastructure economics emerge as decisive variables, reshaping competitive dynamics and defining which players capture value in the […]
Read more

Global deal activity starts on weak note in 2026, says GlobalData

Global deal activity fell sharply year-on-year (YoY) in January 2026, underscoring a broad-based slowdown in risk appetite across markets. The broad-based contraction points to a structural reset in capital allocation priorities, as investors pivot from aggressive expansion to capital preservation, pricing discipline, and execution certainty amid persistent macro and geopolitical volatility, reveals GlobalData, a leading […]
Read more

Soccer dominates EMEA gambling and betting sponsorship in 2025 with over $764 million, reveals GlobalData

EMEA gambling and betting sponsorship is heavily focused on soccer, driven by its unparalleled scale and consistent exposure, making it the top choice for brand visibility and customer reach. With $764.45 million in value, it eclipsed all other listed sports many times in 2025, reveals GlobalData, a leading intelligence and productivity platform. GlobalData’s report, “Sponsorship […]
Read more

Systemic lupus erythematosus and lupus nephritis market to reach $5.9 billion in 7MM by 2034, forecasts GlobalData

The systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the seven major markets (7MM*) is forecast to grow from $2.4 billion in 2024 to $5.9 billion in 2034, at a compound annual growth rate (CAGR) of 9.6%, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Systemic Lupus Erythematosus and […]
Read more

Australia diagnostic imaging market to grow at 5% CAGR through 2036, forecasts GlobalData

Australia’s diagnostic imaging market is steadily advancing, supported by the measured adoption of software-driven and precision-focused medical devices. As healthcare providers prioritize efficiency, functional assessment, and improved clinical decision-making, imaging technologies are becoming increasingly central to care delivery. Against this backdrop, Australia’s diagnostic imaging market is projected to grow at a compound annual growth rate […]
Read more

Global pain market presents significant opportunities for novel mechanisms and modalities, says GlobalData

There is a lack of diversity within the current pain market, with non-steroidal anti-inflammatory drugs (NSAIDs) and opioids dominating the market. With 98% of currently marketed drugs for pain being generics, the pain market provides significant opportunities for innovation and development, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Global Pain […]
Read more
1 … 25 26 27 28 29 … 777